🇺🇸 FDA

Company profile · Sponsor

Beijing

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

C87CE30 · NMPA biotech CN
Pipeline
7
Drugs
0
Patents
0

Quick answer

Beijing (C87CE30) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C87CE30
Exchange NMPA
Company type biotech
Headquarters CN

Pipeline (7)

Search pipeline →

  1. MCV-ACYW135 Vaccine Group

    Beijing

    Meningitis

    phase 3 mab completed

    1 trial

  2. pneumococcal disease prevention

    Beijing

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  3. ICP-022

    Beijing

    Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  4. ICP-022

    Beijing

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  5. BioTTT001 injection

    Beijing

    Locally Advanced Breast Cancer (LABC)

    phase 1 mab terminated

    1 trial

  6. Vagus Nerve Stimulation

    Beijing

    Refractory Epilepsy

    phase 1 other active

    1 trial

  7. YN001

    Beijing

    Cardiovascular Diseases

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Beijing?

Beijing (C87CE30) is a biotech company. headquartered in CN. listed on NMPA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Beijing sponsor?

We track 7 ClinicalTrials.gov-linked programs for Beijing, including MCV-ACYW135 Vaccine Group and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Beijing company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.